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otherObjective: The study objective was to examine the utility of using proteinuria in preoperative risk stratification
for acute kidney injury. Acute kidney injury is a common and important complication for patients undergoing
cardiac surgery. Proteinuria, which reflects structural damage to the glomeruli or renal tubules, may aid the pre-
diction of acute kidney injury.
Methods: The urine albumin to creatinine ratio and dipstick proteinuria concentration were prospectively mea-
sured in 1159 patients undergoing cardiac surgery. The cohort was organized into 4 clinical risk categories based
on the preoperative urine albumin to creatinine ratio: 10 mg/g or less (1.1 mg/mmol), 11 to 29 mg/g (1.2–3.3
mg/mmol), 30 to 299 mg/g (3.4–33.8 mg/mmol), and 300 mg/g or greater (33.9 mg/mmol). The primary out-
come was postoperative acute kidney injury, defined by the Acute Kidney Injury Network stage I criterion
(serum creatinine increase  50% or  0.3 mg/dL; 26.5 mmol/L).
Results:An increase in the incidence of acute kidney injury was noted across the urine albumin to creatinine
ratio categories. Adding the urine albumin to creatinine ratio to the clinical model to predict acute kidney
injury improved the area under the curve from 0.67 to 0.70 (P<.001), and the continuous net reclassification
improvement was 29% (P<.001). The urine albumin to creatinine ratio was also independently associated
with the risk of in-hospital dialysis and intensive care unit and hospital lengths of stay. Surgery status and
preoperative glomerular filtration rate were effect modifiers; the association was stronger among those un-
dergoing elective surgery and those with an estimated glomerular filtration rate of 45 mL/min/1.73 m2 or
greater.
Conclusions: Preoperative proteinuria provides graded stratification risk for acute kidney injury and is an
independent predictor of other outcomes in patients undergoing cardiac surgery. (J Thorac Cardiovasc Surg
2012;143:495-502)Acute kidney injury (AKI) is a common and significant
complication in patients undergoing cardiac surgery. Post-
operatively, AKI is associated with increased hospital
length of stay and in-hospital mortality, and those who sur-
vive AKI have an increased risk of developing chronic kid-
ney disease.1,2 Thus, preoperative prediction of AKI is
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ment of AKI in cardiac surgery is preexisting kidney func-
tion, usually assessed by estimated glomerular filtration rate
(eGFR).3,4 However, another dimension that offers a clue to
the integrity of the kidney is proteinuria as assessed by the
urine albumin to creatinine ratio (UACR) or dipstick
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Abbreviations and Acronyms
AKI ¼ acute kidney injury
AKIN ¼ Acute Kidney Injury Network
AUC ¼ area under the curve
CABG ¼ coronary artery bypass grafting
eGFR ¼ estimated glomerular filtration rate
GFR ¼ glomerular filtration rate
UACR ¼ urine albumin to creatinine ratio
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Mglomeruli or kidney tubules, proteinuria is increasingly rec-
ognized as an important measure of kidney disease6 and risk
factor for the development of AKI.7-10 Proteinuria adds
prognostic value to the GFR for understanding the risks of
AKI,9 cardiovascular disease, and death.11 Urine protein
measurements are readily available and inexpensive, and
can even be assessed at the bedside using a dipstick.
Several prediction models have been published to predict
dialysis (incidence 1%–2%) after cardiac surgery, but none
of these models perform well for prediction of less severe
forms of AKI.12,13 These risk-assessment tools are used to
balance the risks and benefits of cardiac surgery and to mon-
itor the quality of care and outcomes of cardiac surgery by
surgeons and hospitals. Because of the intense scrutiny on
cardiac surgery outcomes, even mild improvements to
help risk adjust for adverse outcomes could have great clin-
ical importance. This may allow clinicians to alter perisur-
gical approaches to minimize AKI or to consider
preventative therapies that prove effective in clinical trials.
Thus, our objective was to examine the utility of urinary
albumin concentrations and urine dipstick measures of pro-
teinuria to stratify for the risk of AKI in patients undergoing
cardiac surgery.MATERIALS AND METHODS
Design and Setting
The participants reported are a subset of the Translational Research In-
vestigating Biomarker Endpoints in Acute Kidney Injury (Clinicaltrials.
gov NCT00774137) cohort. We prospectively enrolled 1219 patients
who were at risk for developing postoperative AKI. The UACR was mea-
sured on available preoperative urine samples (n¼ 1159), and dipstick pro-
teinuria was measured on 1123 samples. Sixty patients did not have the
UACR, and their characteristics were similar to those of the rest of the co-
hort. The cohort included adults undergoing cardiac surgery (coronary ar-
tery bypass grafting [CABG], surgery for valve disease, or both) at 6
academic medical centers in North America between July 2007 and De-
cember 2009. All patients were at high risk for AKI, defined by the pres-
ence of one or more of the following criteria: preexisting renal
impairment (baseline serum creatinine>2 mg/dL [177 mmol/L]), ejection
fraction less than 35% or grade 3 or 4 left ventricular dysfunction, age
more than 65 years, diabetes mellitus, concomitant CABG and valve sur-
gery, or repeat revascularization surgery. Exclusion criteria included prior
kidney transplantation, preoperative advanced chronic kidney disease or
end-stage renal disease, or administration of nephrotoxic drugs
preoperatively.496 The Journal of Thoracic and Cardiovascular SurgAll participants provided written informed subject consent. Each insti-
tution’s research ethics board approved the study.
Sample Collection, Biomarker Measurement, and
Outcomes
A fresh urine sample (10 mL) was collected at the preoperative visit or
on the morning of the surgery. The samples were centrifuged at 1000g for
10 minutes to remove cellular debris. The supernatant was stored at
80C in 1-mL aliquots. All urine albumin assays were measured by im-
munoturbidimetry on a Siemens Dimension Plus with a Heterogeneous
Immunoassay clinical analyzer (Siemens Healthcare Diagnostics, Deer-
field, Ill), per manufacturer’s instructions. Urine creatinine was measured
by the modified Jaffe reaction. The cohort was organized into 4 clinical
risk categories according to the preoperative UACR: 10 mg/g or less
(1.1 mg/mmol), 11 to 29 mg/g (1.2–3.3 mg/mmol), 30 to 299 mg/g
(3.4–33.8 mg/mmol), and 300 mg/g or more (33.9 mg/mmol).7
Urine dipstick was graded as negative, trace, 30 to 99 mg/dL (0.03–
0.099 g/L), and 100 mg/dL or more (0.1 g/L) and measured in the fresh
urine using Siemens Clinitek Status ID number SN48923.
The primary outcome was postoperative AKI based on Acute Kidney
Injury Network (AKIN) stage I (serum creatinine increase  50% or 
0.3 mg/dL [26.5 mmol/L] from the preoperative value or requirement of di-
alysis). The secondary outcome was AKI based on AKIN stage II (serum
creatinine increase  100% or requirement of dialysis).
Statistical Analysis
Demographics, comorbidities, and procedural variables were collected
using definitions of the Society of Thoracic Surgeons (http://www.ctsnet.
org/file/rptDataSpecifications252_1_ForVendorsPGS. pdf). Relative risks
of AKI for the clinical risk categories, adjusted for variables that were
available preoperatively, including demographics, comorbidities, and pro-
cedural variables, were calculated by logistic regression with site as a ran-
dom effect (proc GLIMMIX procedure in SAS 9.2 software, SAS
Institute, Cary, NC). Estimated odds ratios were converted and presented
as relative risks.14 The multivariate clinical model included age (per
year), sex, race, preoperative eGFR calculated by Chronic Kidney Dis-
ease Epidemiology Collaboration equation,15 elective surgery, type of
surgery, cardiac catheterization in past 48 hours, and history of diabetes,
hypertension, chronic congestive heart failure, or myocardial infarction.
These variables have been shown to predict AKI in the cardiac surgery
setting by the Society of Thoracic Surgeons.16 To evaluate the added ef-
fect of UACR on risk discrimination for AKI, we constructed receiver op-
erating characteristic curves and calculated the area under the curve
(AUC) for the UACR alone, the multivariate clinical model alone, and
with the addition of UACR to the clinical model using R 2.11.0 (R Foun-
dation for Statistical Computing, Vienna, Austria). We tested for a statis-
tically significant increase in the AUC using the method developed by
DeLong and colleagues.17 We determined the continuous net reclassifica-
tion improvement as suggested by Pencina and colleagues.18 We evalu-
ated for interaction with the likelihood ratio test on the following
subgroups: age (<65, 65–75, 75–85,>85 years), diabetes, elective versus
urgent surgery, and preoperative stages of eGFR.RESULTS
Of 1159 patients with preoperative UACR measure-
ments, the UACR was 10 mg/g or less in 405 (35%), 11
to 29 mg/g in 355 (31%), 30 to 299 mg/g in 329 (28%),
and 300 mg/g or more in 70 (6%). Characteristics associ-
ated with higher levels of albuminuria included older
age, diabetes, heart failure, ejection fraction less than
40%, higher preoperative serum creatinine, and lowerery c February 2012
TABLE 1. Preoperative characteristics by albuminuria in adults undergoing cardiac surgery
UACR<10 mg/g
(n ¼ 405, 35%)
UACR 11–29 mg/g
(n ¼ 355, 31%)
UACR 30–299 mg/g
(n ¼ 329, 28%)
UACR  300 mg/g
(n ¼ 70, 6%)
P value
for trend
Age (mean, SD) 70.3 (10.4) 71.8 (9.7) 73.0 (9.7) 70.7 (10.6) .003
<65 y (n,%) 97 (24%) 73 (21%) 61 (19%) 19 (27%)
65–75 y 164 (40%) 135 (38%) 118 (36%) 24 (34%)
75–85 y 134 (33%) 133 (37%) 120 (36%) 23 (33%)
>85 y 10 (2.5%) 14 (3.9%) 30 (9.1%) 4 (5.7%)
Male (n,%) 288 (71%) 234 (66%) 225 (68%) 40 (57%) .09
White race (n,%) 384 (95%) 331 (93%) 309 (94%) 60 (86%) .09
Diabetes (n,%) 141 (35%) 137 (39%) 155 (47%) 46 (66%) <.001
Hypertension (n,%) 309 (76%) 280 (79%) 266 (81%) 59 (84%) .06
Myocardial infarction (n,%) 114 (29%) 83 (24%) 70 (22%) 25 (36%) .33
Heart failure (n,%) 96 (24%) 77 (22%) 98 (30%) 25 (36%) .01
Ejection fraction  40% (n,%) 64 (18%) 49 (15%) 84 (28%) 24 (37%) <.001
Operative characteristics (n,%)
Prior cardiac surgery 55 (14%) 43 (12%) 46 (14%) 5 (7%) .58
Elective surgery 306 (76%) 295 (83%) 265 (81%) 54 (77%) .16
Cardiac catheterization in last 48 h 18 (4%) 18 (5%) 23 (7%) 3 (4%) .24
Surgery (n,%) .01
CABG 228 (56%) 148 (42%) 147 (45%) 35 (50%)
Valve 87 (21%) 117 (33%) 114 (35%) 16 (23%)
CABG and valve 90 (22%) 90 (25%) 68 (21%) 19 (27%)
Preoperative medications
ACEI 164 (47%) 162 (48%) 134 (45%) 27 (45%) .56
Angiotensin II receptor blockers 75 (21%) 64 (19%) 74 (25%) 10 (17%) .74
Aspirin 288 (83%) 231 (68%) 216 (72%) 40 (67%) .01
Beta–blockers 258 (74%) 239 (71%) 224 (75%) 52 (87%) .18
Statins 267 (77%) 238 (70%) 217 (73%) 48 (80%) .68
Renal function (mean, SD)
Preoperative serum creatinine (mg/dL)y 1.0 (0.2) 1.0 (0.3) 1.2 (0.4) 1.3 (0.5) <.001
Preoperative eGFR (mL/min/1.73 m2) 70 (17) 71 (19) 63 (21) 57 (22) <.001
<30 mL/min (n,%) 4 (1%) 3 (1%) 19 (6%) 10 (16%)
30 and<45 26 (7%) 29 (10%) 50 (17%) 14 (22%)
45 and<60 76 (21%) 66 (22%) 87 (29%) 13 (20%)
60 252 (70%) 203 (67%) 141 (47%) 27 (42%)
STS bedside score* 19.2 (4.6) 19.9 (5.0) 21.8 (6.3) 24.1 (6.8) <.001
ACEI, Angiotensin-converting enzyme inhibitor; SD, standard deviation; STS, Society of Thoracic Surgeons. *Mehta bedside AKI score without chronic lung disease.16
yTo convert serum creatinine values to mmol/L, multiply by 88.4.
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converting enzyme inhibitors, angiotensin-II receptor
blockers, statins, and b-blockers was not associated with
the albuminuria concentrations.
Renal and Nonrenal Outcomes by Urine Albumin to
Creatinine Ratio Categories
During the postoperative period, stage I AKI or worse
developed in 409 patients (35.2%). The incidence of
AKI increased according to the preoperative UACR: 10
mg/g or less (26% incidence), 11 to 29 mg/g (35%), 30
to 299 mg/g (42%), or 300 mg/g or greater (57%) (P
value for trend< .001). The adjusted relative risk for stage
I AKI increased according to the gradient of the UACR,
with an approximate doubling in AKI risk for the group
with UACR 300 mg/g or more compared with the groupThe Journal of Thoracic and Cawith UACR 10 mg/g or less (Table 2). Stage II AKI or
worse developed in 58 patients (5.0%). The incidence of
stage II or worse AKI also increased according to the gra-
dient of the UACR; however, after multivariate adjustment
the independent association did not meet strict statistical
significance (Table 2). Seventeen patients (1.5%) required
dialysis, of whom 6 died. An additional 13 patients died
without requiring dialysis. UACR categories were inde-
pendently associated with dialysis, length of intensive
care unit stay, and length of hospital stay, but not in-
hospital death (Table 2).
In comparison with other covariates in the final model,
all degrees of albuminuria, including microalbuminuria
(UACR 10–29 mg/g), were comparable or stronger predic-
tor variables for the outcome of stage I AKI than diabetes,
hypertension, chronic heart failure, history of myocardialrdiovascular Surgery c Volume 143, Number 2 497
TABLE 2. Association of preoperative albuminuria and dipstick proteinuria with outcomes
UACR/dipstick categories (n)
Stage I AKI or worse
AKI
cases (n,%)
Unadjusted RR
(95% CI) *
Adjusted RR
(95% CI)y
Albuminuria
UACR<10 mg/g (n ¼ 405) 104 (26%) 1z 1z
UACR 10–29 mg/g (n ¼ 355) 126 (35%) 1.36 (1.09–1.65) 1.35 (1.07–1.66)
UACR 30–299 mg/g (n ¼ 329) 139 (42%) 1.72 (1.42–2.03) 1.64 (1.33–1.97)
UACR  300 mg/g (n ¼ 70) 40 (57%) 2.36 (1.85–2.82) 2.21 (1.66–2.73)
Unadjusted P for trend <.0001
Adjusted P for trend <.0001
Dipstick proteinuria
Negative (n ¼ 720) 218 (30%) 1z 1z
Trace (n ¼ 198) 77 (39%) 1.28 (1.03–1.55) 1.23 (0.98–1.52)
30–99 mg/dL (n ¼ 118) 56 (47%) 1.59 (1.26–1.91) 1.56 (1.22–1.90)
100 mg/dL (n ¼ 87) 41 (47%) 1.62 (1.26–2.00) 1.42 (1.05–1.81)
Unadjusted P for trend <.0001
Adjusted P for trend .006
RR,Relative risk;CI, confidence interval; SD, standard deviation; ICU, intensive care unit; IQR, interquartile range. *Adjusted for site as a random effected. yAdjusted for age (per
year), sex, white race, preoperative eGFR (per mL/min/1.73 m2), diabetes, elective, hypertension, chronic heart failure, cardiac catheterization in past 48 h, myocardial infarction,
and type of surgery. Site is included as a random effect. zReferent. For stage I AKI with UACR, Hosmer–Lemeshow c2 ¼ 10.9, P value .21.
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Minfarction, and combined CABG and valve surgery
(Table 3).Renal and Nonrenal Outcomes by Dipstick
Proteinuria Categories
The risk for stage I AKI increased across the dipstick pro-
teinuria categories, although the relationship was not
graded (P value for trend< .006), and the adjusted relative
risks were slightly less robust than witnessed with the
UACR categories (Table 2). Dipstick proteinuria was not as-
sociated with the risk of stage II AKI or with nonrenal out-
comes after adjustment for covariates.Risk Discrimination for Urine Albumin to Creatinine
Ratio and Dipstick Proteinuria Categories
Addition of UACR to the clinical model increased the
AUC from 0.67 to 0.70 (P<.001), and dipstick proteinuria
increased the AUC for stage I AKI to 0.69 (P ¼ .05, Table
3). The addition of UACR or dipstick proteinuria did not in-
crease the AUC significantly for the prediction of stage II
AKI (Table 4).
UACR and dipstick proteinuria were able to improve risk
classification for AKI. The continuous net reclassification
index was 29% (P < .001) for stage I AKI and 29%
(P ¼ .01) (Figure 1) for stage II AKI with addition of498 The Journal of Thoracic and Cardiovascular SurgUACR to the clinical model and 25% (P ¼ .001) for stage
I AKI and 29% (P ¼ .03) for stage II AKI with addition of
dipstick proteinuria to the clinical model (Table 4).Subgroup and Sensitivity Analysis
We examined the association of UACR and AKI in the
following subgroups: age, diabetes, surgery status, and
eGFR categories (eGFR  60, 45–59, 30–44, and <30
mL/min/1.73 m2). Surgery status and baseline eGFR
were effect modifiers (Table 5). Those with nonelective
surgery and UACR 300 mg/g or greater (33.9 mg/mol)
had a lower relative risk than those with elective surgery
and the same albuminuria group. Higher levels of UACR
were associated with a stepwise increase in the risk for
postoperative AKI in those with eGFR 45 to 59 mL/min/
1.73 m2 and 60 mL/min/1.73 m2 or greater, but were not
associated with increased risk in eGFR 30 to 44 mL/min/
1.73 m2 and less than 30 mL/min/1.73 m2 (Table 5). A sim-
ilar trend was observed with the dipstick proteinuria cate-
gories (data not shown).DISCUSSION
AKI is a major postoperative complication of cardiac
surgery. Even a mild increase in creatinine as small as
0.3 mg/dL (26.5 mmol/L) (AKI stage I) in this setting isery c February 2012
Stage II AKI Other outcomes
AKI cases
(n,%)
Unadjusted RR
(95% CI)
Adjusted RR
(95% CI)y
In- hospital
dialysis (n,%)
Length of stay in ICU, mean
(SD) median [IQR]
Length of stay in hospital,
mean (SD) median [IQR]
13 (3.2%) 1z 1z 4 (1.0%) 3.0 (7.5)
2 [1–2]
7.7 (8.7)
6 [5–8]
18 (5.1%) 1.50 (0.74–2.98) 1.44 (0.70–2.91) 3 (0.9%) 3.3 (10.6)
2 [1–3]
9.1 (13.9)
6 [5–9]
21 (6.4%) 2.11 (1.07–4.03) 1.94 (0.95–3.86) 5 (1.5%) 3.1 (4.4)
2 [1–4]
8.2 (6.5)
7 [5–9]
6 (8.6%) 3.01 (1.16–7.11) 2.59 (0.93–6.58) 5 (7.1%) 7.1 (14.7)
2 [1–6]
12.4 (14.9)
7 [6–11]
.0154 .009 <.0001 <.0001
.07 .0009 .015 .019
30 (4.2%) 1z 1z 7 (1.0%) 2.9 (5.6)
2 [1–3]
8.0 (8.3)
6 [5–8]
15 (7.6%) 1.93 (1.05–3.45) 1.75 (0.93–3.19) 3 (1.5%) 4.2 (14.8)
2 [1–3]
9.5 (16.9)
6 [5–8]
6 (5.1%) 1.22 (0.51–2.79) 1.06 (0.43–2.51) 2 (1.7%) 3.5 (7.8)
2 [1–3]
9.2 (9.5)
7 [5–9]
7 (8.1%) 2.09 (0.92–4.44) 1.86 (0.79–4.09) 5 (5.8%) 5.3 (11.7)
2 [1–4]
10.1 (11.7)
7 [5–10]
.0872 .003 .0004 .0008
.53 .012 .24 .30
TABLE 2. Continued
TABLE 3. Full multivariate models for stage I and II acute kidney
injury
Multivariable adjusted
RR (95% CI) Stage I AKI Stage II AKI
UACR
<10 mg/g 1 1
10–29 1.35 (1.07–1.66) 1.44 (0.7–2.91)
30–299 1.64 (1.33–1.97) 1.94 (0.95–3.86)
300 2.21 (1.66–2.73) 2.59 (0.93–6.58)
Age (per year) 1.003 (0.993–1.013) 0.993 (0.964–1.024)
Female 0.75 (0.60–0.92) 0.91 (0.52–1.6)
White 1.1 (0.76–1.49) 0.98 (0.36–2.48)
eGFR (per mL/min/1.73 m2) 0.993 (0.988–0.998) 0.995 (0.981–1.009)
Diabetes 1.16 (0.96–1.37) 1.10 (0.63–1.92)
Elective 0.60 (0.46–0.76) 0.55 (0.29–1.05)
Hypertension 1.20 (0.94–1.48) 1.70 (0.75–3.70)
Chronic heart failure 1.28 (1.04–1.53) 1.59 (0.86–2.88)
Cardiac catheterization in
past 48 h
1.00 (0.99–1.01) 1.00 (1.00–1.00)
Myocardial infarction 0.95 (0.76–1.16) 1.14 (0.61–2.1)
Type of surgery
Valve 1 1
CABG 0.86 (0.66–1.09) 0.60 (0.28–1.27)
CABG and valve 1.11 (0.88–1.34) 1.52 (0.78–2.87)
CI, Confidence interval; SD, standard deviation.
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study demonstrates that preoperative albuminuria (UACR)
is independently associated with the development of AKI
even after consideration of several important preoperative
characteristics. Furthermore, dipstick proteinuria is also
an independent predictor for the development of stage I
AKI. In addition, preoperative UACR is independently as-
sociated with in-hospital dialysis, intensive care unit length
of stay, and in-hospital length of stay. Both UACR and dip-
stick proteinuria have better prognostic ability for AKI in
patients with eGFR 45 mL/min/1.73 m2 or greater than in
patients with eGFR 45 mL/min/1.73 m2 or less and those
undergoing elective surgery.
Our study builds on the results of Huang and col-
leagues,10 demonstrating that preoperative proteinuria is
an independent risk factor for the development of cardiac
surgery-associated AKI. In their study involving patients
undergoing cardiac surgery, urine dipstick defined as mild
(trace to 1þ) had an adjusted odds ratio of 1.66 for the devel-
opment of AKI (95% confidence interval, 1.09–2.52), and
heavy proteinuria (2þ to 4þ) had an adjusted odds ratio of
2.30 (95% confidence interval, 1.35–3.90). Our study ex-
tends their observations by incorporating UACR for catego-
rization and analyses. Our results are similar to the
nonsurgical setting in which Grams and colleagues7 demon-
strated that UACR is associated with AKI in a gradedThe Journal of Thoracic and Cardiovascular Surgery c Volume 143, Number 2 499
TABLE 4. Risk discrimination and continuous net reclassification
index for stage I and II acute kidney injury by urine albumin to
creatinine ratio and urine dipstick measurements
Stage I AKI Stage II AKI
Area under the ROC curve (SE)
Albuminuria 0.60 (0.02) 0.59 (0.04)
Clinical model 0.67 (0.02) 0.72 (0.04)
Clinical modelþalbuminuria 0.70 (0.02) 0.73 (0.04)
P value* .006 .50
Dipstick 0.57 (0.02) 0.57 (0.04)
Clinical model 0.67 (0.02) 0.73 (0.04)
Clinical modelþdipstick 0.69 (0.02) 0.73 (0.04)
P valuey .027 .70
Continuous Net reclassification index (SE)
Albuminuria 0.29 (0.06) 0.29 (0.14)
P value <.0001 .031
Dipstick 0.25 (0.06) 0.29 (0.14)
P value <.0001 .035
Clinical model includes age (per year), sex, white race, preoperative eGFR (per mL/
min/1.73 m2), diabetes, elective surgery, hypertension, chronic heart failure, cardiac
catheterization in past 48 h, myocardial infarction, type of surgery, and center. ROC,
Receiver operating curve; SE, standard error. *P value comparing the addition of al-
buminuria with the clinical model. yP value comparing the addition of dipstick with
the clinical model.
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that low-grade albuminuria (UACR<30 mg/g), which gen-
erally is not considered pathologic, was independently asso-
ciated with the risk for AKI.FIGURE1. Predicted risk of clinical model with andwithout UACR. Plots show
II AKI and (D) no AKI or stage I AKI for stage II AKI according to the clinical
teinuria added (y-axis). The diagonal line indicates that for points above this lin
points below this line, the predicted risk is lower. AKI, Acute kidney injury.
500 The Journal of Thoracic and Cardiovascular SurgSeveral clinical risk-scoring systems have been devel-
oped and validated to predict the risk of AKI in cardiac sur-
gery. The majority consider severe AKI as the end point
(requiring acute renal replacement therapy).12,13 However,
a few studies developed models for predicting milder
forms of AKI.20,21 Regardless, all the clinical risk scoring
systems, except one,21 solely used preoperative serum cre-
atinine or glomerular filtration rate (GFR) to define chronic
kidney disease. None of the studies examined the added
value of albuminuria or proteinuria to predict AKI in car-
diac surgery. In this multicenter cohort study of patients un-
dergoing cardiac surgery, we found that both preoperative
UACR and dipstick proteinuria add to preoperative risk
stratification for AKI.
These risk-assessment tools are used both to allow indi-
vidual patients and surgeons to balance the risks and ben-
efits of cardiac surgery and to monitor the quality of care
and outcomes of cardiac surgery. Cardiac surgery out-
comes are widely monitored; thus, even mild improve-
ments to help risk adjust for adverse outcomes may have
great clinical and research importance by choosing alter-
native procedures (eg, percutaneous coronary revasculari-
zation or valve repair) and selection of a high-risk
cohort for enrollment into randomized controlled trials.
Therefore, if preoperative proteinuria can be validated fur-
ther as a relevant marker for improving risk assessment for
AKI or other adverse outcomes after cardiac surgery, thenthe predicted risk for (A) AKI and (B) noAKI for stage I AKI and (C) stage
model (x-axis) and to the model with preoperative UACR or dipstick pro-
e, the predicted risk of stage I AKI is higher in the new model and that for
ery c February 2012
TABLE 5. Relative risks (95% confidence interval) of urine albumin to creatinine ratio for acute kidney injury by prespecified subgroups
Variable, (n)
UACR<10 mg/g UACR 11–29 mg/g UACR 30–299 mg/g UACR>300 mg/g
P for trend
n AKI/total (%)
RR (95% CI)y
n AKI/total (%)
RR (95% CI)
n AKI/total (%)
RR (95% CI)
n AKI/total (%)
RR (95% CI)
Age, y
<65 (250) 21/97 (22%)
1
30/73 (41%)
1.8 (1.1–2.6)
26/61 (43%)
2.0 (1.2–2.8)
12/19 (63%)
3.0 (1.8–3.9)
.008
65–75 (440) 39/164 (24%)
1
44/134 (33%)
1.4 (0.9–1.9)
50/118 (42%)
1.9 (1.3–2.4)
16/24 (67%)
3.0 (2.0–3.6)
<.001
75–85 (410) 42/133 (32%)
1
46/134 (34%)
1.1 (0.7–1.5)
50/120 (42%)
1.4 (0.9–1.8)
12/23 (52%)
1.7 (1.0–2.3)
.14
>85 (59) 2/11 (18%)
1
6/14 (43%)
2.3 (0.5–4.6)
13/30 (43%)
2.4 (0.6–4.5)
0/0 (0%) .22
Diabetes
Yes (219) 41/141 (29%)
1
47/137 (34%)
1.1 (0.7–1.5)
76/155 (49%)
1.70 (1.3–2.1)
26/46 (57%)
2.0 (1.4–2.5)
<.001
No (461) 63/264 (24%)
1
79/218 (36%)
1.5 (1.1–1.9)
63/174 (36%)
1.63 (1.2–2.0)
14/24 (58%)
2.5 (1.6–3.3)
.001
Surgery status*
Elective (920) 64/306 (21%)
1
92/295 (31%)
1.4 (1.0–1.78)
105/265 (40%)
1.3 (0.9–1.7)
33/54 (61%)
1.2 (0.6–1.8)
<.001
Nonelective (239) 40/99 (40%)
1
34/60 (57%)
1.4 (1.1–1.8)
34/64 (53%)
2.0 (1.6–2.4)
7/16 (44%)
3.0 (2.3–3.6)
.21
eGFRz
(mL/min/1.73 m2)
<30 (36) 2/4 (50%)
1
3/3 (100%) 8/19 (42%)
0.8 (0.1–1.8)
7/10 (70%)
1.4 (0.3–1.9)
.22
30–44 (119) 10/26 (38%)
1
14/29 (48%)
1.3 (0.6–1.9)
27/50 (54%)
1.4 (0.8–2.0)
6/14 (43%)
1.1 (0.4–1.9)
.61
45–59 (242) 20/76 (26%)
1
23/66 (35%)
1.3 (0.8–2.0)
42/87 (48%)
2.0 (1.3–2.6)
9/13 (69%)
2.8 (1.6–3.5)
.003
60 (762) 72/299 (24%)
1
86/257 (33%)
1.3 (1.0–1.7)
62/173 (36%)
1.6 (1.2–2.0)
18/33 (55%)
2.5 (1.7–3.1)
.005
*P for interaction< .001 for elective vs nonelective surgery. yReferent. zP for interaction ¼ .01 for eGFR  45 vs<45 mL/min/1.73 m2. Site is included as random effect.
Coca et al Perioperative Management
P
Mit could be of value to individual patients, clinicians, hos-
pitals, and trialists.
It has been postulated that proteinuria represents endo-
thelial dysfunction or may injure the kidney itself. There
is a body of evidence that describes proteinuria as toxic to
the tubules. This can result in significant tubulointerstitial
injury and progression of renal disease independently of
the cause of proteinuria in chronic kidney disease. Filtered
albumin when taken up by renal tubular cells via receptor-
mediated endocytosis can trigger expression of a series of
proinflammatory molecules, such as monocyte chemotactic
protein-1, osteopontin, regulated on activation normal
T cell expressed and secreted, and endothelin-1.10 Also,
low molecular weight proteinuria can exacerbate acute is-
chemic injury in experimental animals.22 Patients with al-
buminuria may have some degree of altered functional
renal reserve because of the above mentioned factors and
are more prone to ischemic injury during cardiac surgery.23
We found effect modification by 2 clinical variables: sur-
gery status and preoperative eGFR. Specifically, theThe Journal of Thoracic and Carelationship between the degree of preoperative proteinuria
and the risk for AKI was stronger in those undergoing elec-
tive surgery and those who had higher preoperative eGFR
but was weak or abolished in those undergoing urgent sur-
gery and those with eGFR less than 45 mL/min/m2. These
findings are not surprising. In patients who are already at
higher risk for AKI (urgent surgery and profoundly de-
creased baseline eGFR), it is unlikely that additional param-
eters will provide more information for the risk of
outcomes. However, in patients with lower preoperative
risk, a measure of kidney injury (eg, proteinuria) may pro-
vide additional benefit for risk stratification. For example,
in those with GFR greater than 60 and no albuminuria,
the rate of AKI was 24%. In contrast, the rate of AKI in
those with GFR 30 to 44 was 38%. Thus, because the back-
ground or baseline risk of AKI is already higher in those
with low GFR, it is more difficult to demonstrate higher
risk in association with another predictor variable, in this
case albuminuria. These findings are similar to those of
Tonelli and colleagues,11 who showed that the value ofrdiovascular Surgery c Volume 143, Number 2 501
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Malbuminuria to risk-stratify for the outcomes of end-stage
renal disease and all-cause mortality was greatest in those
with higher baseline eGFR.
The strengths of this study are that it is a multicenter
cohort study involving 6 large academic centers in North
America and representative of contemporaneous surgical
practice. Furthermore, unlike in previous studies,8,9,10
proteinuria was measured by both UACR and dipstick
at the bedside; thus, we were able to compare the 2
methodologies of assessment of proteinuria with the
outcomes. However, there are some limitations to our
study. The majority of the patients in our cohort
experienced only mild AKI (AKIN stage I). The number
of patients with stage II AKI (or worse) was lower,
which may have limited our ability to observe a stable
independent relationship between albuminuria and more
severe AKI. However, the distribution of severity of
AKI reflects the current epidemiology of AKI in cardiac
surgery in the modern era in North America. In
addition, despite the multicenter design of our study,
two thirds of participants were male and more than
90% were white. The ability of the models to correctly
classify patients as AKI or non-AKI using preoperative
variables was only modest, with an AUC of 0.7. Thus, ad-
ditional factors, such as intraoperative and postoperative
events, also influence the ultimate risk for AKI. Finally,
the amount of proteinuria by dipstick can be influenced
by urine concentration.
CONCLUSIONS
Our results indicate that preoperative proteinuria, by both
UACR and urine dipstick, is an independent predictor for
the risk of developing stage I AKI in cardiac surgery.
UACR is also an independent predictor of other important
outcomes, including dialysis and length of stay. However,
with consideration of the cost differential between the 2
tests (40 cents per patient for dipstick and $130 per patient
for UACR), dipstick proteinuria may be a more cost-
effective method to screen patients before surgery because
it still improved risk classification by 24%. This implies
that the number needed to screen via UACR to correctly
classify 1 patient before surgery is 14, at a total cost of
$1820. Future studies will need to determine whether the
additional precision at the expense of increased costs is
worth pursuing and then translates into improved clinical
outcomes. We propose that these widely available tests
that can be performed at the bedside can be used as an aid
in assessing risk for poor outcomes in patients undergoing
cardiac surgery.
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